Why we invest in Varian; using innovation to fight cancer - WHEB

Ty Lee, Associate Fund Manager at WHEB, looks at one of their portfolio holdings, Varian - a global leader in radiation therapy for cancer treatment - and explores its positive social impact.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

... To this case study please click on the button below. 

To the extent that anything on this website constitutes a financial promotion it is exempt from the general prohibition in S21 of FSMA on the basis that the site is only intended for investment professionals as such term is defined in S19 of the Financial Promotions Order. Please note that Pensions for Purpose does not provide consultancy services, advice or personal recommendations on any of the investment opportunities mentioned on the platform. We curate content written by Influencer members and do not endorse any underlying funds.

Learn more here